HHS I.G. Audit: 'Maine Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs'
September 16, 2020
September 16, 2020
WASHINGTON, Sept. 16 -- The Health and Human Services Inspector General issued the following audit report (No. A-07-18-06079) entitled "Maine Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs" filed under the Centers for Medicare and Medicaid Services on Sept. 14:
Why OIG Did This Audit
For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must . . .
Why OIG Did This Audit
For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must . . .